Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FQ79L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,342
Award facts
- Contract value 100% obligated
- $10,342.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,342.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on October 29, 2025, with completion scheduled for October 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a GLP-1 receptor agonist used for weight management, representing the Defense Logistics Agency's continued procurement of specialty pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of contract awards with the Defense Logistics Agency covering a broad spectrum of medications and medical supplies for military healthcare programs worldwide. The company's capability to fulfill this delivery order reflects its established role as a prime vendor in the Defense Logistics Agency's pharmaceutical supply chain supporting military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB26FQ79L?
SPE2DB26FQ79L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FQ79L worth?
The government has obligated $10,342 on SPE2DB26FQ79L.
Is contract SPE2DB26FQ79L an order under another contract?
Yes. SPE2DB26FQ79L is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ79L competed?
The extent of competition for SPE2DB26FQ79L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award